Immunocore to present four posters at AACR Annual Meeting 2023

On March 14, 2023 Immunocore Holdings plc (Nasdaq: IMCR) ("Immunocore" or the "Company"), a commercial-stage biotechnology company pioneering the development of a novel class of T cell receptor (TCR) bispecific immunotherapies designed to treat a broad range of diseases, including cancer, autoimmune and infectious diseases, reported that it will present four posters at the American Association for Cancer Research (AACR) (Free AACR Whitepaper) Annual Meeting 2023 commencing on 14 April 2023 (Press release, Immunocore, MAR 14, 2023, View Source [SID1234628649]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Poster details

Title: Early ctDNA reduction is associated with better overall survival in the Ph 3 trial of tebentafusp in previously untreated metastatic uveal melanoma

Presenting author: Ryan Sullivan
Session: Liquid Biopsies: Circulating Nucleic Acid and Circulating Tumor Cells 1
Date & time: 16 April 2023, 13:30-17:00 (ET)

Title: Melanoma patients with high and low target-expression can benefit from TCR-CD3 bispecifics through direct and indirect mechanisms of tumor control

Presenting author: Esra Güç
Session: Combination Immunotherapies 2
Date & time: 17 April 2023, 13:30-17:00 (ET)

Title: Long-term survival follow-up of tebentafusp in previously treated metastatic uveal melanoma (mUM)

Presenting author: Joe Sacco
Session: Phase II Clinical Trials 2
Date & time: 18 April 2023, 09:00-12:30 (ET)

Title: Evidence of tumor response in orbital lesions treated with tebentafusp in metastatic uveal melanoma patients

Presenting author: Marcus Butler
Session: Late breaking research: clinical research 1/ Endocrinology
Date & time: 17 April 2023, 13:30-17:00 (ET)